Revenue Growth
Achieved sixth consecutive quarter of mid-single-digit growth, with Q2 2025 revenue of approximately $92 million, driven by a 19% increase in unit volumes and strong business-to-business channel performance.
Adjusted EBITDA Profitability
Reported second consecutive quarter of adjusted EBITDA profitability, generating $2 million in adjusted EBITDA, and expected to achieve full-year adjusted EBITDA breakeven in 2025.
Innovation and Product Launches
Introduced Voxi 5, a new stationary oxygen concentrator, and launched an online patient portal to enhance digital health capabilities.
Cash Flow and Financial Health
Increased cash by $1.2 million in the quarter and generated $4.4 million in operating cash flow, with a strong cash position of $123.7 million and no debt outstanding.